340B Manufacturer Fines Outlined In Rule, But HRSA Expects To Use Them ‘Very Rarely’

Proposed rule would implement how civil monetary penalties will be applied to manufacturers that “knowingly and intentionally” deny 340B prices to eligible health care providers.

More from United States

More from North America